XWELL (NASDAQ:XWEL) Announces Earnings Results

XWELL (NASDAQ:XWEL) issued its earnings results on Friday. The company reported ($0.26) earnings per share for the quarter, topping the consensus estimate of ($1.00) by $0.74, Zacks reports. XWELL had a negative return on equity of 2,318.99% and a negative net margin of 81.43%.The firm had revenue of $7.14 million for the quarter, compared to analyst estimates of $2.37 million.

XWELL Trading Down 3.0%

Shares of XWEL stock traded down $0.03 on Friday, hitting $0.98. 10,722 shares of the stock were exchanged, compared to its average volume of 28,262. XWELL has a fifty-two week low of $0.26 and a fifty-two week high of $2.20. The business has a 50-day moving average of $1.07 and a 200 day moving average of $1.08. The firm has a market capitalization of $8.27 million, a P/E ratio of -0.17 and a beta of 1.03.

Analyst Ratings Changes

A number of research firms have commented on XWEL. Wall Street Zen lowered shares of XWELL from a “hold” rating to a “sell” rating in a research note on Sunday, May 17th. Weiss Ratings reiterated a “sell (e+)” rating on shares of XWELL in a research note on Friday, August 7th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Sell”.

About XWELL

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.